Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126595041 | 12659504 | 1 | I | 20160729 | 0 | 20160816 | 20160816 | DIR | 62.66 | YR | F | N | 72.50000 | KG | 20160808 | N | MD | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126595041 | 12659504 | 1 | PS | DOXIL | DOXORUBICIN HYDROCHLORIDE | 1 | CT SCAN 07/12/2016 SHOWED PROGRESSIVE DISEASE. SUBJECT TAKEN OFF STUDY | 0 | 75.6 | MG |
Indications of drugs used
| no results found |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126595041 | 12659504 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126595041 | 12659504 | Cough | |
| 126595041 | 12659504 | Dyspnoea | |
| 126595041 | 12659504 | Fatigue | |
| 126595041 | 12659504 | Oxygen saturation decreased | |
| 126595041 | 12659504 | Pleural effusion |
Reporting Sources (this data is often not reported and may therefore be missing here)
| Event ID | CASEID | RPSR COD |
|---|---|---|
| 126595041 | 12659504 | HP |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126595041 | 12659504 | 1 | 20160705 | 0 |